Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
PRICE T ROWE ASSOCIATES INC /MD/ IBP Installed Building Products, Inc. 13G/A 4.3% 3mo
Hood River Capital Management LLC BAND Bandwidth Inc. 13G 7.64% 3mo
BAMCO INC /NY/ TWFG TWFG, Inc. 13G/A 8.73% 3mo
COHEN & STEERS, INC. UDR UDR, Inc. 13G/A 4.77% 3mo
Vestal Point Capital, LP IBIO iBio, Inc. 13G/A 7.9% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ LPX Louisiana-Pacific Corp 13G/A 4.6% 3mo
Vestal Point Capital, LP ANRO Alto Neuroscience, Inc. 13G/A 2.2% 3mo
Cormorant Asset Management, LP EYPT EyePoint, Inc. 13G/A 8.35% 3mo
James N. Topper ALLO Allogene Therapeutics, Inc. 13G/A 5.6% 3mo
Balyasny Asset Management L.P. NSRX Nasus Pharma Ltd 13G/A 9.99% 3mo
Ikarian Capital, LLC GRTXD Galera Therapeutics, Inc. 13G/A 0% 3mo
Vyacheslav Kim KSPI Joint Stock Co Kaspi.kz 13G/A 20% 3mo
North Reef Capital Management LP ABCB Ameris Bancorp 13G/A 4.06% 3mo
Fort Baker Capital Management LP FAC Factorial Energy Inc. 13G/A 0% 3mo
Point72 Asset Management, L.P. ATRA Atara Biotherapeutics, Inc. 13G/A 7.6% 3mo
American Century Investment Management, Inc. ASIX AdvanSix Inc. 13G 5.1% 3mo
DISCIPLINED GROWTH INVESTORS INC /MN PRLB Proto Labs Inc 13G/A 10% 3mo
ARMISTICE CAPITAL, LLC REVB Revelation Biosciences, Inc. 13G/A 4.99% 3mo
PLATINUM EQUITY, LLC RYZ Ryerson Holding Corp 13G/A 3.7% 3mo
ARMISTICE CAPITAL, LLC BTAIQ BioXcel Therapeutics, Inc. 13G/A 4.99% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC PECE Peace Acquisition Corp. 13G 5.7% 3mo
SAMLYN CAPITAL, LLC VINP Vinci Compass Investments Ltd. 13G 6% 3mo
Fort Baker Capital Management LP TMTS Spartacus Acquisition Corp. II 13G 8.6% 3mo
VAN ECK ASSOCIATES CORP NNE Nano Nuclear Energy Inc. 13G/A 7.3% 3mo
NOMURA HOLDINGS INC CURV Torrid Holdings Inc. 13G/A 5.1% 3mo
Alyeska Investment Group, L.P. DFLI Dragonfly Energy Holdings Corp. 13G/A 3.9% 3mo
Fort Baker Capital Management LP AGLT Agility Robotics, Inc. 13G/A 4.8% 3mo
Polar Asset Management Partners Inc. MYX Maywood Acquisition Corp. 2 13G 9.4% 3mo
Nantahala Capital Management, LLC IKT Inhibikase Therapeutics, Inc. 13G/A 4.3% 3mo
Davidson Kempner Capital Management LP AIB AIB Data Centers Inc. 13G/A 4.61% 3mo
BIOTECHNOLOGY VALUE FUND L P PVLA Palvella Therapeutics, Inc. 13G/A 4.7% 3mo
Harraden Circle Investments, LLC AIIR AIR Global PLC 13G/A 3.12% 3mo
Wasserstein Management, L.P. CLMT Calumet, Inc. 13G/A 4.6% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC BXBL BOXABL Inc. 13G/A 0% 3mo
TENOR CAPITAL MANAGEMENT Co., L.P. HDRN Hadron Energy, Inc. 13G/A 0% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ NRIX Nurix Therapeutics, Inc. 13G 5.3% 3mo
METEORA CAPITAL, LLC DYNC Dynamix Corp 13G/A 13.78% 3mo
Fourthstone LLC CFBK Cf Bankshares Inc. 13G/A 2.49% 3mo
Driehaus Capital Management LLC SEPN Septerna, Inc. 13G/A 9.83% 3mo
Oasis Management Co Ltd. MTN Vail Resorts Inc 13G/A 6.5% 3mo
Hood River Capital Management LLC BFLY Butterfly Network, Inc. 13G 5.61% 3mo
Legal & General Group Plc ZD Ziff Davis, Inc. 13G/A 4.9% 3mo
TENOR CAPITAL MANAGEMENT Co., L.P. TAVI Tavia Acquisition Corp. 13G/A 0% 3mo
Polar Asset Management Partners Inc. IDAC Iron Dome Acquisition I Corp. 13G 6.3% 3mo
MMCAP International Inc. SPC AGLT Agility Robotics, Inc. 13G/A 2.3% 3mo
CANADA PENSION PLAN INVESTMENT BOARD EQH Equitable Holdings, Inc. 13G/A 3.3% 3mo
Trails Edge Capital Partners, LP FTH Faeth Therapeutics, Inc. 13G/A 2% 3mo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. AORT Artivion, Inc. 13G/A 6.5% 3mo
Rubric Capital Management LP ENOV Enovis CORP 13G 6.78% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ SLM SLM Corp 13G 6.6% 3mo